Taro Pharmaceuticals U.S.A., Inc.

Form 483

Hawthorne, New York, United StatesFEI 2435212Issued March 08, 2012

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 2435212.

Observations2

Issue DateMarch 08, 2012

StatusNo Warning Letter

Related Inspections5

Establishment Details

Firm: Taro Pharmaceuticals U.S.A., Inc.
Location: Hawthorne, New York, United States
FEI Number: 2435212
Product Type: Drugs
Issue Date: March 08, 2012
Country: United States

Inspection History, 2009 to 2018

NAI1

VAI4

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Taro Pharmaceuticals U.S.A., Inc. FDA Form 483, Hawthorne, New York, March 8, 2012